404 related articles for article (PubMed ID: 25003284)
1. Epitope analysis of HLA-DQ antigens: what does the antibody see?
Tambur AR; Rosati J; Roitberg S; Glotz D; Friedewald JJ; Leventhal JR
Transplantation; 2014 Jul; 98(2):157-66. PubMed ID: 25003284
[TBL] [Abstract][Full Text] [Related]
2. Eplet Mismatch Load and
Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M
J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139
[TBL] [Abstract][Full Text] [Related]
3. HLA class II DQA and DQB epitopes: recognition of the likely binding sites of HLA-DQ alloantibodies eluted from recombinant HLA-DQ single antigen cell lines.
El-Awar N; Nguyen A; Almeshari K; Alawami M; Alzayer F; Alharbi M; Sasaki N; Terasaki PI
Hum Immunol; 2013 Sep; 74(9):1141-52. PubMed ID: 23756161
[TBL] [Abstract][Full Text] [Related]
4. The DQ barrier: improving organ allocation equity using HLA-DQ information.
Tambur AR; Leventhal JR; Zitzner JR; Walsh RC; Friedewald JJ
Transplantation; 2013 Feb; 95(4):635-40. PubMed ID: 23288109
[TBL] [Abstract][Full Text] [Related]
5. Case report: binding of a clinically relevant human leukocyte antigen-DQα-specific antibody in a kidney graft recipient is inhibited by donor-type human leukocyte antigen-DQβ chain.
Mikkelsen S; Korsholm T; Iburg A; Petersen MS; Møller BK
Transplant Proc; 2013 Apr; 45(3):1209-12. PubMed ID: 23622661
[TBL] [Abstract][Full Text] [Related]
6. Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes.
Wiebe C; Pochinco D; Blydt-Hansen TD; Ho J; Birk PE; Karpinski M; Goldberg A; Storsley LJ; Gibson IW; Rush DN; Nickerson PW
Am J Transplant; 2013 Dec; 13(12):3114-22. PubMed ID: 24164958
[TBL] [Abstract][Full Text] [Related]
7. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients.
Deng CT; El-Awar N; Ozawa M; Cai J; Lachmann N; Terasaki PI
Transplantation; 2008 Aug; 86(3):452-9. PubMed ID: 18698250
[TBL] [Abstract][Full Text] [Related]
8. Anti-HLA Antibody: The Role of Epitopes in Organ Transplantation.
Argani H
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):38-42. PubMed ID: 30777521
[TBL] [Abstract][Full Text] [Related]
9. HLA-DQ mismatches stimulate de novo donor specific antibodies in heart transplant recipients.
Zhang X; Kransdorf E; Levine R; Patel JK; Kobashigawa JA
Hum Immunol; 2020 Jul; 81(7):330-336. PubMed ID: 32307126
[TBL] [Abstract][Full Text] [Related]
10. Terasaki Epitope Mismatch Burden Predicts the Development of De Novo DQ Donor-Specific Antibodies and are Associated With Adverse Allograft Outcomes.
Willicombe M; Blow M; Santos-Nunez E; Freeman C; Brookes P; Taube D
Transplantation; 2018 Jan; 102(1):127-134. PubMed ID: 28731902
[TBL] [Abstract][Full Text] [Related]
11. DQ molecules are the principal stimulators of de novo donor-specific antibodies in nonsensitized pediatric recipients receiving a first kidney transplant.
Tagliamacco A; Cioni M; Comoli P; Ramondetta M; Brambilla C; Trivelli A; Magnasco A; Biticchi R; Fontana I; Dulbecco P; Palombo D; Klersy C; Ghiggeri GM; Ginevri F; Cardillo M; Nocera A
Transpl Int; 2014 Jul; 27(7):667-73. PubMed ID: 24629017
[TBL] [Abstract][Full Text] [Related]
12. Donor selection in pediatric kidney transplantation using DR and DQ eplet mismatching: A new histocompatibility paradigm.
Bryan CF; Chadha V; Warady BA
Pediatr Transplant; 2016 Nov; 20(7):926-930. PubMed ID: 27448994
[TBL] [Abstract][Full Text] [Related]
13. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients.
Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K
Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363
[TBL] [Abstract][Full Text] [Related]
14. Analysis of T and B Cell Epitopes to Predict the Risk of
Sakamoto S; Iwasaki K; Tomosugi T; Niemann M; Spierings E; Miwa Y; Horimi K; Takeda A; Goto N; Narumi S; Watarai Y; Kobayashi T
Front Immunol; 2020; 11():2000. PubMed ID: 32973806
[TBL] [Abstract][Full Text] [Related]
15. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
Yanyiam P; Kantachuvesiri S; Thammanichanond D
Transplant Proc; 2024 Apr; 56(3):515-520. PubMed ID: 38368130
[TBL] [Abstract][Full Text] [Related]
16. Correlations between Terasaki's HLA class II epitopes and HLAMatchmaker-defined eplets on HLA-DR and -DQ antigens.
Marrari M; Duquesnoy RJ
Tissue Antigens; 2009 Aug; 74(2):134-46. PubMed ID: 19497040
[TBL] [Abstract][Full Text] [Related]
17. HLA, Non-HLA Antibodies, and Eplet Mismatches in Pediatric Liver Transplantation: Observations From a Small, Single-Center Cohort.
Ekong UD; Antala S; Bow L; Sese D; Morotti R; Rodriguez-Davalos M; Gan G; Deng Y; Emre SH
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):6-17. PubMed ID: 30777518
[TBL] [Abstract][Full Text] [Related]
18. The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.
Freitas MC; Rebellato LM; Ozawa M; Nguyen A; Sasaki N; Everly M; Briley KP; Haisch CE; Bolin P; Parker K; Kendrick WT; Kendrick SA; Harland RC; Terasaki PI
Transplantation; 2013 May; 95(9):1113-9. PubMed ID: 23514959
[TBL] [Abstract][Full Text] [Related]
19. Antibody-Mediated Rejection Due to Donor-Specific HLA-DQB1 and DQA1 Antibodies After Kidney Transplantation: A Case Report.
Thammanichanond D; Tammakorn C; Worawichawong S; Kantachuvesiri S
Transplant Proc; 2020; 52(6):1931-1936. PubMed ID: 32444122
[TBL] [Abstract][Full Text] [Related]
20. HLA class II DQ epitopes.
Deng CT; Cai J; Tarsitani C; El-Awar N; Lachmann N; Ozawa M
Clin Transpl; 2006; ():115-22. PubMed ID: 18365373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]